G
Guido Bondolfi
Researcher at University of Geneva
Publications - 146
Citations - 6128
Guido Bondolfi is an academic researcher from University of Geneva. The author has contributed to research in topics: Medicine & Mindfulness. The author has an hindex of 33, co-authored 128 publications receiving 5340 citations. Previous affiliations of Guido Bondolfi include Geneva College & GlaxoSmithKline.
Papers
More filters
Journal ArticleDOI
Decreased serum brain-derived neurotrophic factor levels in major depressed patients.
Félicien Karege,Guillaume Perret,Guido Bondolfi,Michèle Schwald,Gilles Bertschy,Jean-Michel Aubry +5 more
TL;DR: It is suggested that major depression is characterized by low serum BDNF levels and support the hypothesis of neurotrophic factor involvement in affective disorders.
Journal ArticleDOI
Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity.
Félicien Karege,Guido Bondolfi,Nicola Gervasoni,Michèle Schwald,Jean-Michel Aubry,Gilles Bertschy +5 more
TL;DR: The results suggest that an alteration of serum or plasma BDNF is probably related to mechanisms of BDNF release and seems to be independent of platelet reactivity; other mechanisms are therefore probably involved and need to be elucidated.
Journal ArticleDOI
Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials
Willem Kuyken,Fiona C Warren,Rod S Taylor,Ben Whalley,Catherine Crane,Guido Bondolfi,Rachel Hayes,Marloes J. Huijbers,Helen Ma,Susanne Schweizer,Zindel V. Segal,Anne E. M. Speckens,John D. Teasdale,Kees Van Heeringen,Mark Williams,Sarah Byford,Richard Byng,Tim Dalgleish,Tim Dalgleish +18 more
TL;DR: Mindfulness-based cognitive therapy appears efficacious as a treatment for relapse prevention for those with recurrent depression, particularly those with more pronounced residual symptoms, as well as other active treatments including antidepressants.
Journal ArticleDOI
Risperidone Versus Clozapine in Treatment-Resistant Chronic Schizophrenia: A Randomized Double-Blind Study
TL;DR: Risperidone was well tolerated and as effective as medium doses of clozapine in patients with chronic schizophrenia who had been resistant to or intolerant of conventional neuroleptics.
Journal ArticleDOI
Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive Episode
Nicola Gervasoni,Jean-Michel Aubry,Guido Bondolfi,Christian Osiek,Michèle Schwald,Gilles Bertschy,Félicien Karege +6 more
TL;DR: It is suggested that antidepressant treatment has a positive effect on serum BDNF levels and support the hypothesis of neurotrophic factor involvement in affective disorders.